TrialEBioMedicine2024

Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma.

Michael P MacManus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.